Mitraclip Secondary Mr denied for failing step therapy by Blue Cross Blue Shield?

Blue Cross Blue Shield's specific coverage criteria for mitraclip secondary mr are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why BCBS Denied MitraClip for Secondary Mitral Regurgitation Under Step Therapy

A step-therapy denial means BCBS requires evidence that you have first tried and had an inadequate response to one or more specified prior treatments before authorizing MitraClip transcatheter edge-to-edge repair. For secondary (functional) mitral regurgitation — which occurs in the setting of cardiomyopathy and heart failure — the step-therapy requirement typically centers on optimization of guideline-directed medical therapy (GDMT) for heart failure and, where applicable, cardiac resynchronization therapy (CRT). BCBS's position is that these treatments must be fully maximized before a procedural intervention is considered.

## Why This Denial Is Appealable

Step-therapy for a device procedure is not the same as a drug step-therapy requirement. If your heart failure team has already optimized GDMT and your chart reflects that optimization, the step-therapy requirement may already be satisfied — the denial may reflect a documentation gap rather than actual non-compliance with the required steps. Additionally, if CRT was considered but is not indicated for your cardiac anatomy or rhythm, your cardiologist can document why that step does not apply to you. The appeal should present the complete treatment history and explain each prior step taken or each step that was clinically inapplicable.

## Federal Appeal Framework

• Internal appeal: Submit within the plan's deadline (typically 180 days). BCBS must respond within 15–30 days (pre-service) or 60 days (post-service).
• External review (ACA §2719 / ERISA §503): Step-therapy denials involving medical judgment are subject to independent external review within approximately four months of the final internal denial.
• Expedited review: If the delay creates clinical urgency, expedited review is available — typically resolved within 72 hours.
• State step-therapy override laws: Many states have enacted step-therapy reform laws requiring insurers to grant exceptions when a required step is contraindicated, previously failed, or clinically inappropriate. Check whether your state's law applies to your plan type.

## Documentation to Gather

1. GDMT medication history: A complete medication reconciliation showing every heart failure therapy tried, with start and stop dates, any titration attempts, and documented reasons for any discontinuation or lack of adequate response. 2. CRT evaluation (if applicable): Documentation that CRT was evaluated — whether implanted (with outcome data), not indicated (with clinical rationale), or already in place without sufficient improvement in MR. 3. Persistent MR documentation: Serial echocardiograms or imaging showing that MR severity has persisted despite optimized therapy. 4. Functional status record: NYHA class or objective functional assessments at multiple time points, demonstrating that symptoms persist despite prior steps. 5. Prescriber letter: A letter from your cardiologist or heart failure specialist summarizing the step-therapy history, documenting each required prior step as satisfied or inapplicable, and explaining why MitraClip is now the appropriate next intervention.

## Criteria-Mapping Structure

Request BCBS's step-therapy policy for TEER in secondary MR. Address each required step:

| Required Step | Status | Documentation | |---|---|---| | GDMT optimized | Completed — [duration] on maximal tolerated therapy | Medication list + cardiology notes | | CRT evaluated/implanted | [Applicable: outcome] or [Not indicated: clinical reason] | EP/cardiology note | | Persistent MR after steps | Confirmed by imaging | Serial echo reports [dates] | | Ongoing symptoms despite therapy | NYHA class documented | Recent visit notes |

This structure converts your treatment history into a direct, criterion-by-criterion rebuttal of the step-therapy denial.